Lilly rides Mounjaro, Zepbound to better
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Related articles
I'm a cruise ship worker...these are the FIVE things smart passengers always do onboard
A cruise ship worker has shared the five things that 'smart' passengers always do when they come abo2024-05-21The US is expected to block aid to an Israeli military unit. What is Leahy law that it would cite?
WASHINGTON (AP) — Israel expects its top ally, the United States, to announce as soon as Monday that2024-05-21Kevin Costner treats his kids to lunch in Montecito while ex
Kevin Costner was a doting dad as he took his kids for Sunday lunch at swanky Italian eatery Tre Lun2024-05-21Poland's prime minister celebrates after his party wins a string of cities in mayoral votes
WARSAW, Poland (AP) — Polish Prime Minister Donald Tusk is celebrating after a series of candidates2024-05-21Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
Travis Kelce was spotted taking a whiskey shot from a slice of bread in true southern fashion as he2024-05-21American defender Sergiño Dest injures a knee. His Copa América availability is in doubt
American defender Sergiño Dest injured a knee during training with PSV Eindhoven, creating doubt whe2024-05-21
atest comment